FDU-PB-22
FDU-PB-22 is a synthetic cannabinoid that has been used in scientific research and has been sold online as a designer drug. It is a potent agonist of the cannabinoid receptors, which are part of the endocannabinoid system.
Chemical Structure
FDU-PB-22 is chemically classified as an indole-based synthetic cannabinoid. Its full chemical name is quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate. The structure of FDU-PB-22 includes a fluoropentyl chain, which is a common feature in many synthetic cannabinoids, contributing to its high potency.
Pharmacology
FDU-PB-22 acts as a potent agonist at the CB1 and CB2 cannabinoid receptors. These receptors are part of the endocannabinoid system, which plays a role in regulating various physiological processes including pain sensation, mood, and appetite. The binding affinity of FDU-PB-22 to these receptors is high, which accounts for its strong psychoactive effects.
Legal Status
The legal status of FDU-PB-22 varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. For example, in the United States, it is listed as a Schedule I controlled substance under the Controlled Substances Act.
Health Effects and Risks
The use of FDU-PB-22 has been associated with a range of adverse health effects. These can include tachycardia, hypertension, nausea, vomiting, and anxiety. Due to its high potency, there is a significant risk of overdose, which can lead to severe health complications or death.
Research and Applications
FDU-PB-22 has been used in scientific research to study the endocannabinoid system and the effects of synthetic cannabinoids. However, due to its potential for abuse and adverse health effects, its use is highly regulated and often restricted to laboratory settings.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
